SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 121 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,736,071 | +2.7% | 162,812 | -3.0% | 0.07% | +6.5% |
| Q2 2023 | $19,221,953 | -30.9% | 167,848 | -16.9% | 0.06% | -38.0% |
| Q1 2023 | $27,830,634 | +948.9% | 201,920 | +886.1% | 0.10% | +1566.7% |
| Q4 2022 | $2,653,280 | +48.3% | 20,476 | +26.5% | 0.01% | +50.0% |
| Q3 2022 | $1,789,000 | -68.1% | 16,184 | -78.4% | 0.00% | -55.6% |
| Q2 2022 | $5,616,000 | -45.8% | 74,915 | -34.9% | 0.01% | +12.5% |
| Q4 2021 | $10,361,000 | +1.3% | 115,055 | +4.0% | 0.01% | -27.3% |
| Q3 2021 | $10,233,000 | +81.1% | 110,652 | +52.3% | 0.01% | +57.1% |
| Q2 2021 | $5,649,000 | -50.3% | 72,659 | -52.4% | 0.01% | -58.8% |
| Q1 2021 | $11,369,000 | -2.5% | 152,538 | +123.1% | 0.02% | -15.0% |
| Q4 2020 | $11,657,000 | +201.3% | 68,372 | +148.1% | 0.02% | +66.7% |
| Q3 2020 | $3,869,000 | +8.2% | 27,553 | -24.6% | 0.01% | -58.6% |
| Q1 2020 | $3,575,000 | +1762.0% | 36,542 | +2352.5% | 0.03% | +2800.0% |
| Q4 2019 | $192,000 | +79.4% | 1,490 | +4.9% | 0.00% | 0.0% |
| Q3 2019 | $107,000 | -96.5% | 1,421 | -97.4% | 0.00% | -95.5% |
| Q4 2017 | $3,085,000 | -65.0% | 55,446 | -71.5% | 0.02% | -72.5% |
| Q3 2017 | $8,816,000 | +511.4% | 194,355 | +354.3% | 0.08% | +433.3% |
| Q2 2017 | $1,442,000 | -60.3% | 42,782 | -65.1% | 0.02% | -64.3% |
| Q1 2017 | $3,631,000 | -66.7% | 122,659 | -78.5% | 0.04% | -67.4% |
| Q2 2016 | $10,892,000 | +787.7% | 571,145 | +808.4% | 0.13% | +658.8% |
| Q1 2016 | $1,227,000 | -89.3% | 62,877 | -78.9% | 0.02% | -87.5% |
| Q4 2015 | $11,501,000 | +17.6% | 298,111 | -2.1% | 0.14% | +0.7% |
| Q3 2015 | $9,781,000 | +39.2% | 304,614 | +31.9% | 0.14% | +37.8% |
| Q2 2015 | $7,029,000 | +293.1% | 230,996 | +71.6% | 0.10% | +250.0% |
| Q1 2015 | $1,788,000 | -14.2% | 134,649 | -6.6% | 0.03% | -9.7% |
| Q4 2014 | $2,085,000 | +22.1% | 144,105 | +78.0% | 0.03% | +19.2% |
| Q3 2014 | $1,708,000 | +18.7% | 80,949 | +67.6% | 0.03% | +18.2% |
| Q2 2014 | $1,439,000 | -35.7% | 48,307 | -48.1% | 0.02% | -42.1% |
| Q1 2014 | $2,237,000 | -43.3% | 93,103 | -51.9% | 0.04% | -36.7% |
| Q4 2013 | $3,945,000 | +804.8% | 193,678 | +1999.0% | 0.06% | +650.0% |
| Q3 2013 | $436,000 | -81.2% | 9,227 | -84.8% | 0.01% | -86.0% |
| Q2 2013 | $2,315,000 | – | 60,853 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |